Onkure Therapeutics, Stock Analysis
| OKUR Stock | 8.05 0.56 6.50% |
OnKure Therapeutics, is overvalued with Real Value of 7.73 and Hype Value of 7.36. The main objective of OnKure Therapeutics, stock analysis is to determine its intrinsic value, which is an estimate of what OnKure Therapeutics, is worth, separate from its market price. There are two main types of OnKure Therapeutics,'s stock analysis: fundamental analysis and technical analysis.
The OnKure Therapeutics, stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. OnKure Therapeutics, is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. OnKure Stock trading window is adjusted to America/New York timezone.
OnKure |
OnKure Stock Analysis Notes
The company had not issued any dividends in recent years. To find out more about OnKure Therapeutics, contact Nicholas Saccomano at 720 307 2892 or learn more at https://onkuretherapeutics.com.OnKure Therapeutics, Investment Alerts
| OnKure Therapeutics, generated a negative expected return over the last 90 days | |
| OnKure Therapeutics, has high historical volatility and very poor performance | |
| OnKure Therapeutics, has a very high chance of going through financial distress in the upcoming years | |
| OnKure Therapeutics, was previously known as Reneo Pharmaceuticals and was traded on NASDAQ Exchange under the symbol RPHM. | |
| Net Loss for the year was (35.31 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OnKure Therapeutics, has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic Data from its First-In-Human PIKture-01 Trial of OKI-219 |
Technical Drivers
As of the 21st of December, OnKure Therapeutics, holds the risk adjusted performance of (0.15), and Coefficient Of Variation of (505.98). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of OnKure Therapeutics,, as well as the relationship between them. Please check OnKure Therapeutics, variance and skewness to decide if OnKure Therapeutics, is priced some-what accurately, providing market reflects its current price of 8.05 per share. Given that OnKure Therapeutics, has information ratio of (0.21), we recommend you to check out OnKure Therapeutics,'s recent market performance to make sure the company can sustain itself at a future point.OnKure Therapeutics, Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. OnKure Therapeutics, middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for OnKure Therapeutics,. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
OnKure Therapeutics, Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific OnKure Therapeutics, insiders, such as employees or executives, is commonly permitted as long as it does not rely on OnKure Therapeutics,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases OnKure Therapeutics, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jansen Valerie Malyvanh over three weeks ago Acquisition by Jansen Valerie Malyvanh of 15300 shares of OnKure Therapeutics, at 18.2 subject to Rule 16b-3 | ||
Manke Isaac over two months ago Acquisition by Manke Isaac of 15300 shares of OnKure Therapeutics, at 18.2 subject to Rule 16b-3 | ||
Leonard Braden Michael over two months ago Acquisition by Leonard Braden Michael of 3457 shares of OKUR New subject to Rule 16b-3 | ||
Saccomano Nicholas A over two months ago Acquisition by Saccomano Nicholas A of 4556 shares of OnKure Therapeutics, subject to Rule 16b-3 |
OnKure Therapeutics, Predictive Daily Indicators
OnKure Therapeutics, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of OnKure Therapeutics, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
OnKure Therapeutics, Forecast Models
OnKure Therapeutics,'s time-series forecasting models are one of many OnKure Therapeutics,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary OnKure Therapeutics,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About OnKure Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how OnKure Therapeutics, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling OnKure shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as OnKure Therapeutics,. By using and applying OnKure Stock analysis, traders can create a robust methodology for identifying OnKure entry and exit points for their positions.
OnKure Therapeutics, is entity of United States. It is traded as Stock on NASDAQ exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding OnKure Therapeutics, to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.